NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Tuesday that its fourth quarter 2013 revenues grew 54 percent year over year and 23 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported Q4 revenues of $9.1 million, compared to just $5.9 million in Q4 2012 and up from $7.4 million in Q3 2013. It matched the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.